News Chart Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-17 pm EDT			5-day change	1st Jan Change
750.57 ^USD	+0.61%		+0.23%	-2.76%

Apr. 15	Sanofi and Regeneron?s Dupixent approval in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria	CI
Apr. 15	Sanofi and Regeneron?S Dupixent Approves in the Eu as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria	CI

31f8ca4d7589cfa4bb3c2670112.Wm-4ELMCRt68U6CsoN0_HE3X0USBMEYPfiEzDDlMltQ.KkLdQNFGHL3GBumb5K5RcDy6qQ6yXzZcOkRRelY2o_k-F_dm1UUIldIykA~5b309ed9eb32557487abbf22809f63ac